早期非小细胞肺癌的新辅助化疗免疫治疗:系统性审查和元分析
Giuseppe Luigi Banna1,2, Mona Ali Hassan1, Alessio Signori3
1Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
JAMA network open
|April 16, 2024
概括
新辅助性免疫检查点抑制剂加上化疗显著改善了早期非小细胞肺癌的无事件生存率和病理完整反应. 这种组合治疗对等待整体生存数据的患者提供了有意义的益处.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 免疫治疗是一种免疫疗法.
背景情况:
- 早期非小细胞肺癌 (NSCLC) 治疗正在发展.
- 新辅助性免疫检查点抑制剂 (ICI) 与化疗 (ICI-化疗) 结合显示出有前途.
- 新辅助性ICI化疗的长期整体生存数据正在等待.
结论:
- 新辅助ICI化疗,特别是基于的治疗方案的3个周期,为早期NSCLC提供了EFS和pCR的有意义的改善.
- 这种方法代表了NSCLC新辅助治疗策略的重大进步.
- 对于整体生存结果,需要进一步的随访.
更多相关视频
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


